On Cost Effectiveness and Sample Size in Clinical Trials

By Augustinus A.M. Hart   Marcel G.W. Dijkgraaf  

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 685-688

Adis International

Access to resources Recommend Favorite

Use of Randomised Controlled Trials for Producing Cost-Effectiveness Evidence: Potential Impact of Design Choices on Sample Size and Study Duration

By Backhouse M.E.  

PharmacoEconomics, Vol. 20, Iss. 15, 2002-01 ,pp. : 1061-1077

Adis International

Access to resources Recommend Favorite

On Cost Effectiveness and Sample Size in Clinical Trials. The Author's Reply

By Martin E. Backhouse  

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 688-689

Adis International

Access to resources Recommend Favorite

Sample Size and Power for Cost-Effectiveness Analysis (Part 1)

By Glick Henry A.  

PharmacoEconomics, Vol. 29, Iss. 3, 2011-03 ,pp. : 189-198

Adis International

Access to resources Recommend Favorite

Sample Size and Power for Cost-Effectiveness Analysis (Part 2): The Effect of Maximum Willingness to Pay

By Glick Henry A.  

PharmacoEconomics, Vol. 29, Iss. 4, 2011-04 ,pp. : 287-296

Adis International

Access to resources Recommend Favorite